Low- and middle-income countries (LMICs) are undergoing a significant health transformation. While once predominantly ...

Bristol Myers Squibb Co. closed $2.39 below its 52-week high ($61.08), which the company reached on November 11th.

LONDON (Reuters) - Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert ...

Despite billions poured into research, new medicines still typically take a decade or more to develop.

Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for ...

Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...

BMS has been among the pharma giants that have bought into AI for drug discovery. In 2021, the company struck a $1.2 billion ...

Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out ...

We recently published a list of 10 Stocks That Are Close To Becoming Dividend Aristocrats. In this article, we are going to ...

It's been a challenging past few years for Bristol Myers Squibb (NYSE: BMY). The company's financial results dipped following ...

The moves will affect more than 300 employees across both companies as both firms look to drive growth in the long term.